Colorectal cancer screening in elderly patients: When should be more useful?

Cancer Treatment Reviews

Volumn 33, Issue 6, 2007, Pages 528-532

  Pasetto, Lara Maria ^a   Monfardini, Silvio ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Colorectal cancer; Elderly; Screening

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; BARIUM ENEMA; CANCER MORTALITY; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONSENSUS DEVELOPMENT; EARLY DIAGNOSIS; ELDERLY CARE; HEALTH STATUS; HUMAN; INDIVIDUALIZATION; INFORMED CONSENT; LIFE EXPECTANCY; MEDICAL DECISION MAKING; OCCULT BLOOD; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POLYPECTOMY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SIGMOIDOSCOPY; TIME; VETERAN;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONOSCOPY; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INCIDENCE; MIDDLE AGED; TIME FACTORS;

EID: 34548487763     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2007.04.004     Document Type: Review

References (26)

1. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics 1999. Cancer J Clin 49 (1999) 8-31
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer Incidence in Five Continents, vol. VII, IARC Scientific Publications No. 143, Lyon: IARC Press; 1997.
3. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 1 (2004) 3-27
4. Kemppainen M., Raiha I., Rahala T., and Sourander L. Delay of diagnosis in colorectal cancer in the elderly. Age Ageing 22 4 (1993) 260-264
5. Harewood G.C., Lawlor G.O., and Larson M.V. Incident rates of colonic neoplasia in older patients: When should we stop screening?. J Gastroenterol Hepatol 21 6 (2006) 1021-1025
6. Lin O.S., Kozarek R.A., Schembre D.B., et al. Screening colonoscopy in very elderly patients: Prevalence of neoplasia and estimated impact on life expectancy. JAMA 295 20 (2006) 2411-2412
7. Gill T.M., Baker D.I., Gottschalk M., et al. A program to prevent functional decline in physically frail elderly persons who live at home. N Engl J Med 347 (2002) 1068-1070
8. Ko C.W., and Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology 129 4 (2005) 1342-1344
9. Kirchgatterer A., Hubner D., Aschl G., Hinterreiter M., Stadler B., and Knoflach P. Colonoscopy and sigmoidoscopy in patients aged eighty years or old. Z Gastroenterol 40 12 (2002) 951-956
10. Cooper G.S., and Payes J.D. Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer 103 4 (2005) 696-701
11. Ladabaum U., and Phillips K.A. Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med 30 5 (2006) 378-384
12. Harewood G.C., and Lawlor G.O. Incident rates of colonic neoplasia according to age and gender: Implications for surveillance colonoscopy intervals. J Clin Gastroenterol 39 10 (2005) 894-899
13. Stevens T., and Burke C.A. Colonoscopy screening in the elderly: when to stop?. Am J Gastroenterol 98 8 (2003) 1881-1885
14. Wolf A.M., and Schorling J.B. Does informed consent alter elderly patients' preferences for colorectal cancer screening? Results of a randomised trial. J Gen Int Med 15 1 (2000) 24-30
15. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med 328 (1993) 672
16. Mandel J.S., Church T.R., Ederer F., et al. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91 (1999) 434-437
17. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
18. Kronborg O., Fenger C., Olsen J., et al. Randomized study of screening for colorectal cancer with faecal occult blood test. Lancet 348 (1996) 1467-1471
19. Kewenter J., Brevenge H., Engaras B., Haglind E., and Ahren C. Results of screening, rescreening and follow-up in a prospective randomised study for detection of colorectal cancer by faecal occult blood testing. Results of 68,308 subjects. Scand J Gastroenterol 29 (1994) 468-473
20. Tazi M.A., Faivre J., Dassonville F., Lamour J., Milan C., and Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: Results of five screening rounds from 1988 to 1996. J Med Screening 4 (1997) 147-151
21. Faivre J., Tazi M.A., Milan C., Lejeune C., Durand G., and Lamour J. Controlled trial of faecal occult blood screening for colorectal cancer in Burgundy (France). Results of the first 9 years. Gastroenterology 116 (1999) A400 summary
22. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2006. Ca Cancer J Clin 56 (2006) 11-25
23. Recommendations on cancer screening in the European Union. Advisory Committee on Cancer Prevention. Eur J Cancer, 2000;36:1473-8.
24. Simon J.B. Fecal occult blood testing: Clinical value and limitations. Gastroenterologist 6 (1998) 66-78
25. Frazier A.L., Colditz G.A., Fuchs C.S., et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284 (2000) 1954-1961
26. Kemeny M.M., Bush-Devearaux E., Merriam L.T., et al. Cancer surgery in the elderly. Hematol/Oncol Clin N Am 14 (2000) 169-192